Answers are grounded in this paper and cite their sources.
Background Evidence-based guidance in older adults (≥65 years) with psoriasis is sparse and undertreatment might be present.Objectives To assess prescribing patterns, comfort levels, barriers and needs of dermatologists when treating older adults with systemic antipsoriatic therapy.Methods A mixed-methods design was used including a survey among all Dutch dermatologists and residents, followed by semi-structured interviews.Results Most of the survey respondents applied systemic treatment to the same extent in older versus younger patients (n = 49; 67.1%) and weren’t reluctant prescribing systemic therapy (n = 50; 68.5%) in older adults. However, 26% (n = 19) of the respondents treated older adults less often with systemic therapy compared to younger patients and 68.1% (n = 49) performed additional actions in older adults, e.g. intensified monitoring or dose reduction. Based on the survey and interviews (n = 10), the main reasons for these age-based treatment differences were comorbidity, comedication, and fear of adverse events. More evidence-based guidance, education, and time to assess older adults were identified as most important needs, especially regarding frailty screening.Conclusions Age-based treatment differences in and reluctance to treating older adults with systemic antipsoriatic therapy were common. There is a need for more evidence-based guidance, education, and consultation time, to improve treatment in this growing population.
No takes yet. Share an insight, caveat, or question.
Haar et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: